Photo

902-701-6645 / 613-801-3476

...

Ottawa, Vancouver

English

Michael Maskery, Ph.D.

Patent Agent

Michael Maskery’s practice focuses on the patent drafting, prosecution and strategy in a variety of technology fields, including wireless and wired networks, communication and control systems, electronics, and computer-related technologies. Michael’s expertise extends to software and firmware design and computer automated systems as well as the electrical and mechanical arts.  Michael also conducts and coordinates prior art searches and performs patent analysis for validity, infringement, and due diligence cases.

Michael’s doctoral work focused on the analysis and design of decentralized, wireless-enabled systems with applications in the areas of wireless sensor networks, defence, and radio spectrum access. Michael has also worked to develop active queue management algorithms for TCP data networks, and has previously worked as a Protection and Control Engineer and a Test Engineer.  Michael has co-authored several journal articles, book chapters, and has presented his work at various international conferences.

Michael splits his time between Ottawa and Vancouver based clients.

Education

  • B.Sc., Mathematics and Electrical Engineering, Queen’s University

  • M.Sc., Mathematics, University of Ottawa

  • Ph.D., Electrical Engineering, University of British Columbia

Professional Involvement

  • BCTIA (British Columbia Technology Industries Association)

Technology Area

cb photo 124 561ead1bced0d

DR. POONAM TAUH

Patent Agent


Poonam’s focuses on the drafting and prosecution of pharmaceutical, chemical, biochemical, petrochemical, and polymer patent applications around the world.
MBM read_more_btn

 

MBM logo

About MBM

 The process of invention is complete only with the IP protection provided in law. That's where MBM comes in. We match our clients' creative thinking with the creative protection needed to achieve their goals.Read More About MBM

Clarifications to the Data Protection Guidance Document

Health Canada recently announced that section 2.1 of its Guidance Document re: Data Protection has been amended to clarify that the prior approval of a medicinal ingredient in a drug for veterinary use will not preclude the granting of data protection for a drug for...Read More